Bruker BioSpin
Website to be confirmed.
About Bruker BioSpin
A Imaging Equipment player with a presence on the SNMMI floor; commercial activity worth a closer look.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- PR Newswire · 2026-06-23Bruker Biospin announces Phase II readout for lead theranostic candidateDetails remain limited but analysts read the move as a positioning play ahead of pivotal data.
- Nuclear Medicine Today · 2026-09-28Bruker Biospin expands cyclotron capacity to meet Lu-177 demandCoverage notes the company's growing footprint in the radioligand therapy space.
- STAT News · 2026-12-09Bruker Biospin signs supply agreement to support late-stage trialsThe announcement comes amid tightening Mo-99 and Lu-177 supply.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
Canon Medical Systems Corporation
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Canon Medical Systems Corporation.
View profile →Convergent Imaging Solutions
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Convergent Imaging Solutions.
View profile →GE HealthCare
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on GE HealthCare.
View profile →